The results demonstrate for the first time that ferroptosis is upregulated in PCOS and that the therapeutic or protective effect of CRY may be mediated by inhibition of this process which is a regulator of the HMGB1/MAPK/ERK pathway involved in the regulation of many pathological processes. This evidence concerns the gene HMGB1 and polycystic ovary syndrome.